The Effects of Intranasal Oxytocin on Social Cognition and Social Approach Behaviors in Opioid-dependent Patients
Phase of Trial: Phase 0
Latest Information Update: 20 May 2016
Price : $35 *
At a glance
- Drugs Oxytocin (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- Acronyms MOO
- 06 Oct 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 14 Jan 2014 Inclusion and exclusion criteria as well as time frames for all endpoints are amended.
- 21 Dec 2012 New trial record